March 12 (Reuters) - Mallinckrodt Pharmaceuticals
and Endo ( NDOI ) are exploring a potential merger
that could be valued at about $7 billion, Bloomberg News
reported on Wednesday, citing people with knowledge of the
matter.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Arun
Koyyur)